Form 4: Sera Prognostics Executive Sells Shares
Insider Transaction (Form 4)
Tiffany Eul Davis Inglis, Chief Medical Officer of Sera Prognostics, Inc., sold 486 shares of common stock on September 10, 2026 for $2.00 per share.
Summary
- Open-market sale: disposed of 486 Class A Common Stock at $2.00 ($972) on September 10, 2026; holds 91,589 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $972 of stock on the open market.
Insider Transactions
Tiffany Eul Davis Inglis — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Open-market sale | Class A Common Stock | 486 | $2 | $972 | 91,589 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Open-market sale (486 shares) |
Keywords
insider transaction, Form 4, SERA, SERA PROGNOSTICS, INC., bearish, Tiffany Eul Davis Inglis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.